Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|
EPS | $0.0 | ($0.1) | ($0.9) | ($0.6) | ($0.5) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, LifeStance Health Group, Inc.'s last 12-month EPS is ($0.3), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, LifeStance Health Group, Inc.'s EPS growth was (50.8%). The average annual EPS growth rates for LifeStance Health Group, Inc. have been 60.3% over the past three years, N/A over the past five years.
Over the last year, LifeStance Health Group, Inc.'s EPS growth was (50.8%), which is lower than industry growth of 0.6%. It indicates that LifeStance Health Group, Inc.'s EPS growth is Bad.